arrow
D

Djamila E. Issa

Jeroen Bosch Ziekenhuis
H指数:15
被引数:714

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Fatigue, Neuropathy and Psychological Distress and Their Association With Health-Related Quality of Life in Survivors of Diffuse Large B-Cell Lymphoma: A Prospective Cohort Study and Comparison With a Normative Population

疲劳、神经病变和心理困扰及其与弥漫性大B细胞淋巴瘤幸存者健康相关生活质量的关联:一项前瞻性队列研究及与常模人群的比较

2025-11-070
PRE
Challenges in predicting outcomes for watch and wait follicular lymphoma patients: insights into clinical, pathological, and molecular factors

预测观察等待策略下滤泡性淋巴瘤患者预后的挑战:临床、病理及分子因素的见解

2025-10-010
PRE
Atezolizumab consolidation in patients with high-risk diffuse large B-cell lymphoma in complete remission after R-CHOP

Atezolizumab巩固治疗在完成R-CHOP治疗后达到完全缓解的高危弥漫性大B细胞淋巴瘤患者中的应用

2025-04-210
OA
Impact of comorbidity on health-related quality of life in newly diagnosed patients with lymphoma or multiple myeloma: results from the PROFILES-registry
2024-09-160
PRE
Ixazomib, daratumumab and low-dose dexamethasone in intermediate-fit patients with newly diagnosed multiple myeloma: an open-label phase 2 trial
2023-09-016
OAAI
Immunogenicity of the 13-Valent Pneumococcal Conjugated Vaccine Followed by the 23-Valent Polysaccharide Vaccine in Chronic Lymphocytic Leukemia

13价肺炎球菌结合疫苗和23价多糖疫苗在慢性淋巴细胞白血病中的免疫原性

2023-07-044
OAAI
Venetoclax consolidation after fixed-duration venetoclax plus obinutuzumab for previously untreated chronic lymphocytic leukaemia (HOVON 139/GiVe): primary endpoint analysis of a multicentre, open-label, randomised, parallel-group, phase 2 trial
2022-03-0119
OAAI
Web-Based Return of Individual Patient-Reported Outcome Results Among Patients With Lymphoma: Randomized Controlled Trial
2021-12-1410
OAAI
Rituximab and the risk of transformation of follicular lymphoma: a retrospective pooled analysis
2018-08-0188
PREAI